Close Menu
  • FDA
  • Categories
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Breast
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • Gastrointestinal
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Kidney
    • Liver
    • Lung
    • Lymphoma
    • Melanoma and Skin
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Prostate
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • MOASC
    • Upcoming Oncology Conferences
  • About
  • Contact
  • Advertise
Advertisement
X (Twitter) LinkedIn Facebook
X (Twitter) LinkedIn Facebook YouTube
OncologyTube
  • FDA
  • Categories
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Breast
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • Gastrointestinal
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Kidney
    • Liver
    • Lung
    • Lymphoma
    • Melanoma and Skin
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Prostate
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • MOASC
    • Upcoming Oncology Conferences
  • About
  • Contact
  • Advertise
Subscribe
OncologyTube
Home » ASCO 2022 Breast Cancer Cancer Question & Answer
Breast

ASCO 2022 Breast Cancer Cancer Question & Answer

EditorBy EditorSeptember 19, 2022No Comments1 Min Read
Twitter LinkedIn Facebook Email
Share
Twitter LinkedIn Facebook Email

Question and Answer Session

Kay Yeung, MD, Ph.D. – ASCO [2022] Breast Cancer In-Depth Slides: MOASC

https://oncologytube.com/v/41294

Kay Yeung, MD, Ph.D. – ASCO [2022] Breast Cancer Overview: MOASC Spotlight

https://oncologytube.com/v/41282

Kay Yeung, MD, Ph.D. – About The Author, Credentials, and Affiliations

Her primary area of expertise is in the clinical oncology treatment of breast cancer patients, for which she holds board certification. In order to provide patients with the most effective range of treatment options, she employs a variety of therapeutic approaches, including endocrine therapy, chemotherapy, targeted therapy, and immunotherapy.

She is also a teacher at the UC San Diego School of Medicine, where she is an associate professor of medicine where she instructs medical school students, residents, and fellows. Dr. Yeung did both her residency in internal medicine and her hematology/(clinical) oncology fellowship at the University of California, San Diego School of Medicine, where she also served as a head fellow during her time there.

Breast cancer Kay Yeung MOASC Question and Answer UC San Diego Health
Follow on X (Twitter) Follow on LinkedIn Follow on Facebook Follow on Google News
Share. Twitter LinkedIn Facebook Email

Related Posts

ASCO 2025 Top 10 Abstracts

ASCO 6 Mins Read

Top 10 Breast Cancer Trials to Watch at ASCO 2025: OncologyTube Exclusive

ASCO 3 Mins Read

ASCO 2025 Guidelines on Sentinel Lymph Node Biopsy for Early-Stage Breast Cancer: A Game-Changer in Oncology

ASCO 5 Mins Read
Recent Posts
  • CHALLENGE Trial at ASCO 2025: Exercise Extends Life for Colon Cancer Survivors
  • ATOMIC Trial Results at ASCO 2025: Breakthrough for dMMR Stage III Colon Cancer
  • Cancer of Unknown Primary Diagnostics: Insights for Oncologists and Researchers
  • BRAFTOVI BREAKWATER Trial: Survival Results at ASCO 2025
  • AI in Oncology: Transforming Cancer Care at ASCO 2025
Connect With Us on Social
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
Donate
X (Twitter) LinkedIn Facebook YouTube
  • FDA
  • Categories
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Breast
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • Gastrointestinal
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Kidney
    • Liver
    • Lung
    • Lymphoma
    • Melanoma and Skin
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Prostate
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • MOASC
    • Upcoming Oncology Conferences
  • About
  • Contact
  • Advertise
© 2025 Copyright Protected Medicus Networks, Inc. Privacy Policy

Type above and press Enter to search. Press Esc to cancel.